Belgium· BE-AMP-SAM002073-00
Hexomedine 1 mg/g - 0.5 mg/g
A hexamidine product containing tetracaine hydrochloride, registered in Belgium by Melisana.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Tetracaine Hydrochloride
- Manufacturer
- Melisana
- Country
- Belgium (BE)
- ATC code
- R02AA18
- ATC class
- Hexamidine
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb0115063
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hexamidine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBLT 3CENTURA PHARMACEUTICALS INC
- United KingdomAmetop 4% gelAlliance Pharmaceuticals Ltd
- NorwayAmetopAlliance Pharmaceuticals
- CanadaAMETOP GEL 4%VALEO PHARMA INC
- SpainANESTESIA TOPICA B. BRAUN 10 mg/ml SOLUCIONB Braun Medical S.A.
- IrelandAmetop 40 mg/g GelAlliance Pharma (Ireland) Limited
- FinlandMinims AmethocaineChauvin Pharmaceuticals Limited
- NetherlandsMinims Tetracainehydrochloride 10 mg/ml, oogdruppels, oplossingBausch + Lomb Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Germany · Tetracain-Hcl Smartpractice Europe
- Spain · Lubristesic, Tetracaína Lainco
- France · Tetracaine Thea
- United Kingdom (Northern Ireland) · Ametop, Anethaine
- Greece · Tetracaine Hydrochloride Cooper
- Ireland · Ametop, Minims
- Luxembourg · Minims, Minims Tetracaine Chlorhydrate Bausch + Lomb Ireland Limited
- Netherlands · Minims Tetracainehydrochloride, Tetracaïnehydrochloride Minims Bausch + Lomb Ireland
- Norway · Tetrakain Minims Bausch + Lomb Ireland Limited
- Sweden · Tetrakain Bausch & Lomb
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a26b1414-17eb-40a5-9db0-5c73657904ea GET /v1/drugs/a26b1414-17eb-40a5-9db0-5c73657904ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oromucosal spray, solution",
"source": "afmps",
"status": "REVOKED",
"name_en": "Hexomedine 1 mg/g - 0.5 mg/g",
"name_fr": "Hexomedine 1 mg/g - 0.5 mg/g",
"name_nl": "Hexomedine 1 mg/g - 0.5 mg/g",
"amp_code": "SAM002073-00",
"strengths": [
"0.0150",
"0.0150",
"0.0300",
"0.0300",
"0.0198",
"7.5000",
"0.0150",
"4.8210"
],
"pack_count": 1,
"substances": [
"Tetracaine Hydrochloride",
"Hexamidine Diisetionate",
"Ethanol",
"Glycerol",
"Sodium Acetate",
"Sucrose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Hexamidine",
"authorisation_numbers": [
"BE002073"
]
}See everything about hexamidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.